Ceradyne (CRDN) Reports Q3 EPS of $0.26; Guides FY10
More News related to CRDN
- Jesup & Lamont Upgrades Harris Stratex Networks (HSTX) to Buy
- Morgan Joseph Maintains a 'Hold' on Ceradyne (CRDN), Suspends Estimates
- Ceradyne (CRDN) Receives $12.4M Order for SAPI Body Armor from U.S. Army RDECOM
- Ceradyne, Inc. Receives $12.4 Million SAPI Body Armor Order
- Ceradyne (CRDN) Lowers FY09 Sales Guidance, Reiterates FY10
More News related to Earnings
- HNI Corporation (HNI) Tops Q1 EPS by 2c; Revs Light
- Team Health (TMH) Reports Mixed Q4 Results
- Baidu (BIDU) Blows the Lid Off Q4, Shares Jump
- Aspen Insurance (AHL) Posts Q4 adj.-EPS of $1.44, Tops Views
- Acadia Realty Trust (AKR) Misses Q4 FFO by 1c; Guides Below for FY10
Ceradyne (NASDAQ: CRDN) reports Q3 EPS of $0.26, versus the analyst estimate of $0.28. Revenue for the quarter was $108 million, which compares to the estimate of $109.30 million.
Guides FY10 revs to $380 - $430 million, and EPS from $0.60 - $1.05.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.71Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
